KCM
PCRX icon

Kingdon Capital Management’s Pacira BioSciences PCRX Stock Holding History

Kingdon Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Hold
0
– – – 131
2018
Q2 		– Hold
0
– – – 138
2016
Q3 		– Sell
-211,500
Closed -$7.13M – 141
2016
Q2 		$7.13M Buy
+211,500
New +$10.4M 0.58% 65
2013
Q4 		– Sell
-67,784
Closed -$3.26M – 219
2013
Q3 		$3.26M Sell
67,784
-9,000
-12% -$328K 0.24% 145
2013
Q2 		$2.23M Buy
+76,784
New +$2.22M 0.2% 161

Other funds holding PCRX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return